Harvard Bioscience (HBIO) Divestments (2013 - 2023)

Harvard Bioscience (HBIO) reported Divestments of $512000.0 for Q1 2023, up 2944.44% quarter-over-quarter from -$18000.0 in Q4 2019.

Harvard Bioscience (HBIO) Divestments (2013 - 2023) Analysis & Trends

Harvard Bioscience (HBIO) has 5 years of Divestments data on file, last reported at $512000.0 in Q1 2023.

Divestments for Q1 2023 came in at $512000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $512000.0 (changed N/A YoY), and the FY2023 annual result was $512000.0, changed N/A from the prior year.
Divestments advanced to $512000.0 in Q1 2023 per HBIO's latest filing, from -$18000.0 in the prior quarter.
Over five years, Divestments peaked at $1.0 million in Q2 2019 and troughed at -$18000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	-
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	-
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	-
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	-
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	-
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	-
10	Harvard Bioscience	26.17 Mn	19.07 Mn	12.24 Mn	-

Download Data